Brinzolamide/Brimonidine Tart
Brand name: Simbrinza
Rank #371 of 500 drugs by total cost
$26.3M
Total Cost
97,240
Total Claims
$26.3M
Total Cost
2,943
Prescribers
$271
Cost per Claim
14,482
Beneficiaries
145,450
30-Day Fills
$8,946
Avg Cost/Provider
33
Avg Claims/Provider
About Brinzolamide/Brimonidine Tart
Brinzolamide/Brimonidine Tart (sold as Simbrinza) was prescribed 97,240 times by 2,943 Medicare Part D providers in 2023, costing the program $26.3M. At $271 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 368 | Ursodiol (Ursodiol) | $26.6M | 123,719 |
| 369 | Glycerol Phenylbutyrate (Ravicti) | $26.6M | 268 |
| 370 | Doravirine (Pifeltro) | $26.4M | 14,437 |
| 371 | Brinzolamide/Brimonidine Tart (Simbrinza) | $26.3M | 97,240 |
| 372 | Rotigotine (Neupro) | $26.2M | 23,665 |
| 373 | Chlorpromazine Hcl (Chlorpromazine Hcl) | $25.9M | 78,710 |
| 374 | Perampanel (Fycompa) | $25.9M | 20,876 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology